STATE STREET CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,238,484
-25.1%
2,266,569
+0.6%
0.00%
Q2 2023$5,657,477
+2543.4%
2,253,975
+1743.0%
0.00%
Q1 2023$214,025
-71.4%
122,300
-30.4%
0.00%
Q4 2022$747,150
-2.7%
175,800
-43.9%
0.00%
Q1 2022$768,000
-15.3%
313,401
-7.0%
0.00%
Q4 2021$907,000
-46.1%
337,114
+0.3%
0.00%
Q3 2021$1,684,000
-12.1%
336,198
+31.0%
0.00%
Q2 2021$1,915,000256,7000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 6,304,705$15,824,8100.09%
Virtus ETF Advisers LLC 55,763$139,9650.08%
VANCE WEALTH, INC. 39,266$98,5580.04%
CSS LLC/IL 266,514$668,9500.04%
SHELL ASSET MANAGEMENT CO 322,738$8100.03%
Steward Partners Investment Advisory, LLC 600,000$1,506,0000.02%
Alpine Global Management, LLC 30,000$75,3000.02%
SECTORAL ASSET MANAGEMENT INC 50,000$125,5000.02%
BENDER ROBERT & ASSOCIATES 24,059$60,3880.02%
HoyleCohen, LLC 74,408$186,7650.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders